Biotech Companies Settle Secretive Patent Suit
The settlement originates from a patent case that was filed in April 2001, and dismissed on Oct. 30, 2002 on the basis that the parties were settling the case. It is unclear why the settlement took four years.
The case concerned three patents. Two, owned by Promega Corp., are called “Multiplex amplification of short...
To view the full article, register now.